Long-term efficacy of psoriasis vulgaris treatments: Analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010

被引：4

作者：

Akasaka, Emiko ^{[1
]}

Mabuchi, Tomotaka ^{[1
]}

Manabe, Yasuaki ^{[1
]}

Yahagi, Eiichiro ^{[1
]}

Yamada-Hiruma, Azusa ^{[1
]}

Yamaoka, Hanako ^{[1
]}

Kojima, Tomoko ^{[1
]}

Kato, Masayuki ^{[1
]}

Ikoma, Norihiro ^{[1
]}

Ozawa, Akira ^{[1
]}

Haruki, Yasuo ^{[2
]}

机构：

[1] Tokai Univ, Sch Med, Dept Dermatol, Isehara, Kanagawa 2591193, Japan

[2] Tokai Univ, Sch Med, Dept Basic Med Sci, Isehara, Kanagawa 2591193, Japan

来源：

JOURNAL OF DERMATOLOGY | 2013年 / 40卷 / 04期

关键词：

background characteristics; classification of changes in severity; long-term efficacy; psoriasis vulgaris; treatment;

D O I：

10.1111/1346-8138.12069

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

Various therapies have been tried for psoriasis. In Japan, biologics began to be used for psoriasis treatment in January 2010. Their clinical efficacy is well known, but biologics cannot be used in all psoriasis patients for reasons such as side-effects and cost. It is necessary to evaluate the effect of long-term psoriasis treatment, but there have been no reports evaluating long-term treatment. Therefore, the outcomes of patients who had been treated at the Tokai University Hospital for more than 5years, before biological agents were released, were examined. Three categories, classified by initial severity, changes in severity by method of treatment and background characteristics, were investigated. In conclusion, cases of long-term treatment with a combination of topical corticosteroid and topical vitamin D3 analog or oral cyclosporin were found to be effective therapies. Patients with a history of diabetes mellitus or cardiovascular disease of psoriasis were likely to be treatment resistant.

引用

页码：238 / 243

页数：6

共 15 条

[1]

Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review [J].

Archier, E. ;

Devaux, S. ;

Castela, E. ;

Gallini, A. ;

Aubin, F. ;

Le Maitre, M. ;

Aractingi, S. ;

Bachelez, H. ;

Cribier, B. ;

Joly, P. ;

Jullien, D. ;

Misery, L. ;

Paul, C. ;

Ortonne, J-P ;

Richard, M-A .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 :11-21

[2]

Ciclosporin in psoriasis clinical practice: an international consensus statement [J].

Griffiths, CEM ;

Dubertret, L ;

Ellis, CN ;

Finlay, AY ;

Finzi, AF ;

Ho, VC ;

Johnston, A ;

Katsambas, A ;

Lison, AE ;

Naeyaert, JM ;

Nakagawa, H ;

Paul, C ;

Vanaclocha, F .

BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 :11-23

[3]

Griffiths CEM, 2004, ROOKS TXB DERMATOLOG, V35, P20

[4]

A survey of psoriasis patients in Japan from 1982 to 2001 [J].

Kawada, A ;

Tezuka, T ;

Nakamizo, Y ;

Kimura, H ;

Nakagawa, H ;

Ohkido, M ;

Ozawa, A ;

Ohkawara, A ;

Kobayashi, H ;

Harada, S ;

Igarashi, A .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2003, 31 (01) :59-64

[5]

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents [J].

Menter, Alan ;

Korman, Neil J. ;

Elmets, Craig A. ;

Feldman, Steven R. ;

Gelfand, Joel M. ;

Gordon, Kenneth B. ;

Gottlieb, Alice B. ;

Koo, John Y. M. ;

Lebwohl, Mark ;

Lim, Henry W. ;

Van Voorhees, Abby S. ;

Beutner, Karl R. ;

Bhushan, Reva .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (03) :451-485

[6]

Clinical severity of psoriasis in last 20 years of PUVA study [J].

Nijsten, Tamar ;

Looman, Caspar W. N. ;

Stern, Robert S. .

ARCHIVES OF DERMATOLOGY, 2007, 143 (09) :1113-1121

[7]

Ohtsubo H, 1993, NISHINIHON J DERMATO, V55, P86

[8]

European S3-Guidelines on the systemic treatment of psoriasis vulgaris [J].

Pathirana, D. ;

Ormerod, A. D. ;

Saiag, P. ;

Smith, C. ;

Spuls, P. I. ;

Nast, A. ;

Barker, J. ;

Bos, J. D. ;

Burmester, G-R ;

Chimenti, S. ;

Dubertret, L. ;

Eberlein, B. ;

Erdmann, R. ;

Ferguson, J. ;

Girolomoni, G. ;

Gisondi, P. ;

Giunta, A. ;

Griffiths, C. ;

Hoenigsmann, H. ;

Hussain, M. ;

Jobling, R. ;

Karvonen, S-L ;

Kemeny, L. ;

Kopp, I. ;

Leonardi, C. ;

Maccarone, M. ;

Menter, A. ;

Mrowietz, U. ;

Naldi, L. ;

Nijsten, T. ;

Ortonne, J-P ;

Orzechowski, H-D ;

Rantanen, T. ;

Reich, K. ;

Reytan, N. ;

Richards, H. ;

Thio, H. B. ;

van de Kerkhof, P. ;

Rzany, B. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 :1-70

[9]

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study [J].

Paul, CF ;

Ho, VC ;

McGeown, C ;

Christophers, E ;

Schmidtmann, B ;

Guillaume, JC ;

Lamarque, V ;

Dubertret, L .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) :211-216

[10]

Pearce D J, 2004, J Dermatolog Treat, V15, P235, DOI 10.1080/09546630410033745

← 1 2 →